Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK) HKSE

0.14

+0(+0.00%)

Updated at November 07 03:19PM

Currency In HKD

Valuation

Market Cap256.88M
Enterprise Value78.89M
P/E Ratio35.6
PEG Ratio-0.61
Price/Sales Ratio0.22
Price/Book Ratio0.31
Enterprise/Revenue0.18
Enterprise/EBITDA4.76

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.01
Operating Margin0.01

Management Effectiveness

Return On Assets0.01
Return On Equity0.01

Income Statement

Revenue1.04B
Revenue/Share0.59
Gross Profit328.04M
EBITDA62.87M
Net Income25.01M
Diluted EPS0.01

Balance Sheet

Total Cash139.33M
Total Cash/Share0.08
Total Debt101.89M
Total Debt/Equity0.14
Current Ratio2.08
Book Value Per Share0.46

Price History

52-Week Change5.93
52-Week High0.38
52-Week Low0.13
Moving Average 50 Days0.15
Moving Average 200 Days0.18

Statistics

Average Volume668,387
Shares Outstanding1.68B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.15
Trailing Annual Dividend Yield114.7
Payout Ratio39.69
Last Split FactorN/A
Last Split DateN/A